Ionis Pharmaceuticals マネジメント
マネジメント 基準チェック /24
Ionis Pharmaceuticalsの CEO はBrett Moniaで、 Jan2020年に任命され、 の在任期間は 4.83年です。 の年間総報酬は$ 12.50Mで、 7.7%給与と92.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.11%を直接所有しており、その価値は$ 5.69M 。経営陣と取締役会の平均在任期間はそれぞれ4.8年と8.5年です。
主要情報
Brett Monia
最高経営責任者
US$12.5m
報酬総額
CEO給与比率 | 7.7% |
CEO在任期間 | 4.8yrs |
CEOの所有権 | 0.1% |
経営陣の平均在職期間 | 4.8yrs |
取締役会の平均在任期間 | 8.5yrs |
経営陣の近況
Recent updates
Ionis Pharmaceuticals: Catalysts Due In 2025/2026 Are Extremely Compelling
Oct 23There Is A Reason Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Price Is Undemanding
Aug 24Ionis Pharmaceuticals: Harnessing RNA-Targeted Therapies For Long-Term Shareholder Value
Aug 11Health Check: How Prudently Does Ionis Pharmaceuticals (NASDAQ:IONS) Use Debt?
Jul 28Ionis: Tough Run For Share Price Belies Multiple Reasons For Optimism
May 28Analysts Have Made A Financial Statement On Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) First-Quarter Report
May 09Lacklustre Performance Is Driving Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Low P/S
Apr 14Is Ionis Pharmaceuticals (NASDAQ:IONS) Using Debt Sensibly?
Mar 18Ionis Pharmaceuticals 2023 Earnings Review: Short-Term Pain, Long-Term Gain
Feb 23Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Investors Are Less Pessimistic Than Expected
Dec 28Ionis Pharmaceuticals (NASDAQ:IONS) Has Debt But No Earnings; Should You Worry?
Dec 07A Look At The Intrinsic Value Of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Nov 16Ionis Pharmaceuticals (NASDAQ:IONS) Has Debt But No Earnings; Should You Worry?
Aug 03Is Ionis Pharmaceuticals (NASDAQ:IONS) Using Debt Sensibly?
May 05Does Ionis Pharmaceuticals (NASDAQ:IONS) Have A Healthy Balance Sheet?
Jan 20Ionis Pharmaceuticals Looks Good For The Long Term
Oct 19Ionis plans for new manufacturing site in California to support pipeline
Oct 13Ionis: 2 Drug Advancements With Potential Firsts
Aug 29Ionis Pharmaceuticals Q2 2022 Earnings Preview
Aug 08CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$359m |
Jun 30 2024 | n/a | n/a | -US$366m |
Mar 31 2024 | n/a | n/a | -US$385m |
Dec 31 2023 | US$13m | US$961k | -US$366m |
Sep 30 2023 | n/a | n/a | -US$409m |
Jun 30 2023 | n/a | n/a | -US$309m |
Mar 31 2023 | n/a | n/a | -US$329m |
Dec 31 2022 | US$7m | US$825k | -US$270m |
Sep 30 2022 | n/a | n/a | US$7m |
Jun 30 2022 | n/a | n/a | -US$28m |
Mar 31 2022 | n/a | n/a | -US$4m |
Dec 31 2021 | US$13m | US$800k | -US$29m |
Sep 30 2021 | n/a | n/a | -US$608m |
Jun 30 2021 | n/a | n/a | -US$550m |
Mar 31 2021 | n/a | n/a | -US$495m |
Dec 31 2020 | US$11m | US$700k | -US$444m |
Sep 30 2020 | n/a | n/a | US$94m |
Jun 30 2020 | n/a | n/a | US$145m |
Mar 31 2020 | n/a | n/a | US$169m |
Dec 31 2019 | US$7m | US$528k | US$281m |
Sep 30 2019 | n/a | n/a | US$433m |
Jun 30 2019 | n/a | n/a | US$402m |
Mar 31 2019 | n/a | n/a | US$366m |
Dec 31 2018 | US$4m | US$508k | US$277m |
Sep 30 2018 | n/a | n/a | -US$41m |
Jun 30 2018 | n/a | n/a | -US$38m |
Mar 31 2018 | n/a | n/a | US$9m |
Dec 31 2017 | US$2m | US$443k | US$19m |
報酬と市場: Brettの 総報酬 ($USD 12.50M ) は、 US市場 ($USD 7.74M ) の同規模の企業の平均を上回っています。
報酬と収益: Brettの報酬は増加しましたが、会社は利益を上げていません。
CEO(最高経営責任者
Brett Monia (63 yo)
4.8yrs
在職期間
US$12,500,023
報酬
Dr. Brett P. Monia, Ph.D. is a Founder of Ionis Pharmaceuticals, Inc. in 1989 and has been Chief Executive Officer since January 2020. He has extensive experience across a range of therapeutic areas, inclu...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Founder | 4.8yrs | US$12.50m | 0.11% $ 5.7m | |
Executive VP of Finance & CFO | 11.8yrs | US$2.89m | 0.059% $ 3.2m | |
Director | 6.8yrs | US$538.04k | 0.055% $ 3.0m | |
Executive VP & Chief Development Officer | 16.3yrs | US$2.56m | 0.054% $ 2.9m | |
Executive Vice President of Research | 4.8yrs | US$2.56m | 0.021% $ 1.2m | |
Chief Accounting Officer & Senior VP | 4.8yrs | データなし | データなし | |
Executive VP & Chief Scientific Officer | 4.8yrs | US$958.87k | 0.050% $ 2.7m | |
Senior Vice President of Investor Relations | no data | データなし | データなし | |
Executive VP | 11.8yrs | US$3.92m | 0.031% $ 1.7m | |
Vice President of Corporate Communications | less than a year | データなし | データなし | |
Senior Vice President of Human Resources | 4.8yrs | データなし | 0.0050% $ 269.0k | |
Scientific Advisor | 3.4yrs | US$2.28m | データなし |
4.8yrs
平均在職期間
64.5yo
平均年齢
経験豊富な経営陣: IONSの経営陣は 経験豊富 であると考えられます ( 4.8年の平均在職年数)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Founder | 5.7yrs | US$12.50m | 0.11% $ 5.7m | |
Director | 24.2yrs | US$538.04k | 0.055% $ 3.0m | |
Independent Director | 5.4yrs | US$540.04k | 0.027% $ 1.4m | |
Independent Director | 18.9yrs | US$542.04k | 0.010% $ 559.6k | |
Lead Independent Director | 30.8yrs | US$598.04k | 0.084% $ 4.5m | |
Independent Director | 6.2yrs | US$528.04k | 0.020% $ 1.1m | |
Independent Director | 22.5yrs | US$548.04k | 0.096% $ 5.2m | |
Independent Chairman of the Board | 10.8yrs | US$568.04k | 0.020% $ 1.1m | |
Independent Director | 3.4yrs | US$530.04k | 0.010% $ 534.3k | |
Independent Director | less than a year | US$363.05k | データなし |
8.5yrs
平均在職期間
70yo
平均年齢
経験豊富なボード: IONSの 取締役会 は 経験豊富 であると考えられます ( 8.5年の平均在任期間)。